News

Singapore-based Invida Pharmaceutical Holdings will market Sancuso in Australia, Indonesia, the Philippines, Thailand and Vietnam, while Dubai-based NewBridge Pharmaceuticals will market Sancuso in Turkey. ProStrakan has already partnered

Widely published in scientific journals and with over 100 invited presentations, Caniggia also serves as a reviewer for a number of leading peer-reviewed scientific journals and has been

The offer replaces the previous proposal made by Roche in July 2008 to acquire all of the publicly held shares of Genentech at a price of $89 per

Revenues for the second quarter decreased $404,012 or 16.8% vs. the prior year’s comparable quarter; of this, $179,365 was a reduction in contract manufacturing revenue primarily due to

In the primary analysis, there was no statistically significant difference between maribavir and placebo in reducing the rate of cytomegalovirus (CMV) disease. In addition, the study failed to

The study successfully demonstrated the tolerability of the two concentrations tested for continuous application to the skin for a period of one week. Additionally, there was no systemic

Xoma, a biopharmaceutical company, and Takeda Pharmaceutical Company have expanded their existing collaboration to provide Takeda with access to multiple antibody technologies, including a suite of R&D technologies

The reduction in costs is targeted at Akela’s development programs, as well as its service business, PharmaForm. Akela has initiated the Phase III clinical trials in its lead

The new contract is expected to generate $5 million in sales for Medline, while CHS is in line to realize a 20% supply cost savings through formulary standardization,